Hongxin Cao

机构：First Affiliated Hospital of Xi'an Jiaotong University

发表论文 77 篇 · 总被引 1507 次 · h-index 24

代表论文

• SLC39A10 promotes malignant phenotypes of gastric cancer cells by activating the CK2-mediated MAPK/ERK and PI3K/AKT pathways (2023 · Experimental & Molecular Medicine · 被引 58)
• Risk factors for venous thromboembolism following spinal surgery (2020 · Medicine · 被引 44)
• Dipeptidyl Peptidase-4 Stabilizes Integrin α4β1 Complex to Promote Thyroid Cancer Cell Metastasis by Activating Transforming Growth Factor-Beta Signaling Pathway (2022 · Thyroid · 被引 30)
• Characterization of the functional effects of ferredoxin 1 as a cuproptosis biomarker in cancer (2022 · Frontiers in Genetics · 被引 29)
• Disulfiram/Cu Kills and Sensitizes BRAF-Mutant Thyroid Cancer Cells to BRAF Kinase Inhibitor by ROS-Dependently Relieving Feedback Activation of MAPK/ERK and PI3K/AKT Pathways (2023 · International Journal of Molecular Sciences · 被引 27)
• Exosomal MiR-199a-5p Inhibits Tumorigenesis and Angiogenesis by Targeting VEGFA in Osteosarcoma (2022 · Frontiers in Oncology · 被引 20)